Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Metabarcoding bat guano samples

PROVIDER: PRJNA752700 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15364700_1.fastq.gz	Fastqsanger.gz
	SRR15364700_2.fastq.gz	Fastqsanger.gz
	SRR15364800_1.fastq.gz	Fastqsanger.gz
	SRR15364800_2.fastq.gz	Fastqsanger.gz
	SRR15364900_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 610

Similar Datasets

Project description:Guano metabarcoding

| PRJNA759421 | ENA

Chiroptera

Project description:Effect of aerobic exposure on bat guano samples

| PRJNA412917 | ENA

Bat guano bacterial community

Project description:Bat guano bacterial community Raw sequence reads

| PRJNA429934 | ENA

bat metagenome

Project description:Bat samples

| PRJNA275773 | ENA

gut metagenome

Project description:bat guano and cave soil strain:mixed Raw sequence reads

| PRJNA301769 | ENA

Project description:First report of CC5-MRSA-IV-SCCfus "Maltese clone" in Bat Guano

| PRJNA734263 | ENA

Project description:Metagenomic analysis of bat guano sampled in Cabalyorisa and tinmori Caves in Mabini, Pangasinan and Determination of the Efficacy and Safety of the Bat Guano as Organic Agricultural Fertilizer

| PRJNA377355 | ENA

pattern of miR-22 knockout mouse BAT gene expression

Project description:To further understand different gene expression of miR-22 knockout mouse BAT and normal BAT, we have employed BAT samples microarray expression profiling as a discovery platform to identify different genes with miR-22 knockout mouse BAT and normal BAT.comparision with normal BAT,significantly upgene is 522 and downgene is 720 in knockout group.

2020-04-01 | GSE147835 | GEO

Project description:Metabarcoding Malaise trap samples

| PRJNA706915 | ENA

Bispecific antigen therapy plasma proteome

Project description:Bispecific-antibody therapy (BAT), the next strategy of immunotherapy for tumor patients, has showed the enhanced antitumor benefits than the monotherapy. Yet, few effective biomarkers were developed to monitor the response. Here, we investigated the first BAT longitudinal plasma proteome profiling including 86 longitudinal samples from 22 tumor patients who received anti-PD1 and anti-CTLA4 BAT therapy and 24 healthy control samples, which might be beneficial to explore the biomarker for BAT.

2024-02-20 | PXD039260 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data